Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-08 7:22 pm Sale |
2023-12-31 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
Beryl Capital Management LLC | 0 0.000% |
-4,426,381 (Position Closed) |
Filing History |
| 2023-09-05 4:39 pm Purchase |
2023-08-24 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
Beryl Capital Management LLC | 4,426,381 8.200% |
4,426,381 (New Position) |
Filing History |
| 2023-08-24 5:23 pm Purchase |
2023-08-14 | 13D | Zynerba Pharmaceuticals, Inc. ZYNE |
Harmony Biosciences Holdings Inc. HRMY |
7,592,498 13.130% |
7,592,498 (New Position) |
Filing History |
| 2022-02-14 3:52 pm Sale |
2022-02-11 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
ETF MANAGERS GROUP LLC | 3,526,304 8.560% |
-1,087,028 (-23.56%) |
Filing History |
| 2021-06-01 2:00 pm Purchase |
2021-05-28 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
ETF MANAGERS GROUP LLC | 4,613,332 11.180% |
2,404,548 (+108.86%) |
Filing History |
| 2021-05-11 1:13 pm Purchase |
2021-05-10 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
ETF MANAGERS GROUP LLC | 2,208,784 5.350% |
298,590 (+15.63%) |
Filing History |
| 2021-03-11 11:12 am Sale |
2021-03-09 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
ETF MANAGERS GROUP LLC | 1,910,194 4.630% |
-90,394 (-4.52%) |
Filing History |
| 2021-02-10 12:04 pm Sale |
2020-12-31 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
The Vanguard Group | 1,035,402 3.520% |
-638,560 (-38.15%) |
Filing History |
| 2021-02-05 8:34 pm Sale |
2020-12-31 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
Michael Rapoport | 0 0.000% |
-1,490,000 (Position Closed) |
Filing History |
| 2021-01-08 1:04 pm Purchase |
2021-01-07 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
ETF MANAGERS GROUP LLC | 2,000,588 6.800% |
421,427 (+26.69%) |
Filing History |
| 2020-11-16 12:05 pm Purchase |
2020-11-13 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
ETF MANAGERS GROUP LLC | 1,579,161 5.360% |
371,035 (+30.71%) |
Filing History |
| 2020-07-10 10:39 am Sale |
2020-06-30 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
BLACKROCK INC BLK |
438,643 1.800% |
-1,074,962 (-71.02%) |
Filing History |
| 2020-05-11 2:43 pm Sale |
2020-05-08 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE |
ETF MANAGERS GROUP LLC | 1,208,126 4.840% |
-1,475,277 (-54.98%) |
Filing History |